SLP:NASDAQ
Simulations Plus Inc
$18.44
arrow_upward
+0.05%(+0.010) 1D
$18.44
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 17, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SLP...
Open
$18.44
High
$18.45
Low
$18.43
Mkt. cap
372.95M
Avg. vol.
178.36K
Volume
1.00
P/E ratio
46.07
52-wk high
$21.01
52-wk low
$11.09
EPS
$0.40
Beta
1.33
Shares outstanding
20.22M
No. of employees
213
Open
$18.44
High
$18.45
Low
$18.43
Mkt. cap
372.95M
Avg. vol.
178.36K
Volume
1.00
P/E ratio
46.07
52-wk high
$21.01
52-wk low
$11.09
EPS
$0.40
Beta
1.33
Shares outstanding
20.22M
No. of employees
213
News stories
From web sources and news partners
Stock Titan
·
13 hours ago
The FDA will use new software to assess cosmetic safety
MarketBeat
·
2 days ago
Squarepoint Ops LLC Sells 58,282 Shares of Simulations Plus, Inc. $SLP
CarePlus VietNam
·
1 month ago
SLP Q2 2026 Earnings: EPS Delivers 40.7% Beat While Revenue Disclosure Remains Pending - CEO Earnings Statement
Profile
Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services. Wikipedia
About Simulations Plus Inc
CEO-
Employees213
Founded1996
HeadquartersLancaster, California, United States
SectorHealth care
Websitesimulations-plus.com